AnaptysBio Stock Price - ANAB

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
AnaptysBio Inc ANAB NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.01 -0.09% 10.99 11.48 10.6205 11.00 11.00 11:20:29
Bid Price Ask Price Spread Spread % News
10.99 11.02 0.03 0.27% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,905 531,053 $ 10.99 $ 5,836,357 895,630 9.16 - 83.10
Last Trade Time Type Quantity Stock Price Currency
11:20:29 3 $ 10.99 USD

AnaptysBio Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 297.25M 27.05M $ -61.66M -2.50 - 26.64M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

AnaptysBio News

Date Time Source News Article
11/08/201908:09Edgar (US Regulatory)Quarterly Report (10-q)
11/08/201908:06Edgar (US Regulatory)Current Report Filing (8-k)
11/08/201908:05GlobeNewswire Inc.AnaptysBio Announces Third Quarter 2019 Financial Results..
11/08/201908:00GlobeNewswire Inc.AnaptysBio Reports Etokimab ATLAS Phase 2b Clinical Trial in..
9/30/201916:19Edgar (US Regulatory)Current Report Filing (8-k)
9/30/201916:15GlobeNewswire Inc.AnaptysBio Reports Positive Topline Data from Interim..
9/27/201906:30GlobeNewswire Inc.AnaptysBio to Present at the Cantor Fitzgerald Global..

Latest ANAB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ANAB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week37.8838.519.1610.565,694,402-26.89-70.99%
1 Month36.5039.489.1613.181,575,030-25.51-69.89%
3 Months43.2646.349.1620.66750,225-32.27-74.6%
6 Months72.4779.099.1632.06502,614-61.48-84.84%
1 Year70.7583.109.1644.45389,389-59.76-84.47%
3 Years16.00134.009.1661.99328,971-5.01-31.31%
5 Years16.00134.009.1661.99328,971-5.01-31.31%

AnaptysBio Description

AnaptysBio Inc is a US-based clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements.
Your Recent History
NASDAQ
ANAB
AnaptysBio
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191114 16:35:46